Soligenix’s (SNGX) Buy Rating Reaffirmed at Maxim Group

Maxim Group reaffirmed their buy rating on shares of Soligenix Inc (OTC:SNGX) in a report released on Monday, StockTargetPrices.com reports. The firm currently has a $4.00 target price on the stock.

Soligenix (OTC:SNGX) traded down 4.09% during trading on Monday, reaching $2.11. The company had a trading volume of 26,422 shares. Soligenix has a 52-week low of $2.10 and a 52-week high of $14.40. The company’s market capitalization is $11.97 million. The company has a 50 day moving average price of $2.47 and a 200 day moving average price of $2.56.

COPYRIGHT VIOLATION NOTICE: This piece of content was first posted by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The correct version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/2655676/soligenixs-sngx-buy-rating-reaffirmed-at-maxim-group-2.html.

Soligenix Company Profile

Soligenix, Inc is a late-stage biopharmaceutical company. The Company is focused on developing and commercializing products to treat rare diseases. The Company operates through two segments: BioTherapeutics and Vaccines/BioDefense. Its BioTherapeutics segment is developing a photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL), formulations of oral beclomethasone 17,21-dipropionate (BDP) for the prevention/treatment of gastrointestinal (GI) disorders characterized by severe inflammation, and its innate defense regulator (IDR) technology, dusquetide (SGX942) for the treatment of oral mucositis in head and neck cancer.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “OTC:SNGX”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Stock Target Prices

Receive News & Ratings for Soligenix Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Soligenix Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
President Trump Hurting Tourism in the U.S.
President Trump Hurting Tourism in the U.S.
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Blue Apron Filed Thursday for Public Offering
Blue Apron Filed Thursday for Public Offering
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Large Auto Lender Checked Just 8% of Incomes for Applicants
Large Auto Lender Checked Just 8% of Incomes for Applicants


Leave a Reply

© 2006-2017 Ticker Report. Google+.